Pteridium spp. and Bovine Papillomavirus: Partners in Cancer
- 1Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal
- 2Veterinary Sciences Department, University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal
- 3Veterinary Sciences Department, State University of Maranhão (UEMA), São Luís, Brazil
- 4Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP)/Rede de Investigação em Saúde (RISE)@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (Porto.CCC), Porto, Portugal
- 5Molecular Oncology and Viral Pathology Group, Faculty of Medicine, University of Porto, Porto, Portugal
- 6Biomedicine Research Center (CEBIMED), Faculty of Health Sciences, Fernando Pessoa University, Porto, Portugal
- 7Virology Service, Portuguese Institute of Oncology (IPO-Porto), Porto, Portugal
- 8LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Porto, Portugal
- 9Post-graduate Programme in Adult Health (PPGSAD), Department of Morphology, Federal University of Maranhão (UFMA), UFMA University Hospital (HUUFMA), São Luís, Brazil
A Corrigendum on
Pteridium spp. and Bovine Papillomavirus: Partners in Cancer
by Medeiros-Fonseca, B., Abreu-Silva, A. L., Medeiros, R., Oliveira, P. A., and Gil da Costa, R. M. (2021). Front. Vet. Sci. 8:758720. doi: 10.3389/fvets.2021.758720
In the original article, funder FCT, 2020.07675.BD was not included. The corrected Funding statement appears below.
Funding
This work was supported by the Research Center of the Portuguese Oncology Institute of Porto (project no. PI86-CI-IPOP-66-2017); by European Investment Funds by FEDER/COMPETE/POCI-Operational Competitiveness and Internationalization Program, and National Funds by FCT-Portuguese Foundation for Science and Technology under projects UID/AGR/04033/2020, UIDB/CVT/00772/2020 and by Base Funding-UIDB/00511/2020 of the Laboratory for Process Engineering, Environment, Biotechnology, and Energy LEPABE-funded by national funds through the FCT/MCTES (PIDDAC); Project 2SMART-engineered Smart materials for Smart citizens, with reference NORTE-01-0145-FEDER-000054, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). BM-F was supported by FCT, 2020.07675.BD.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: papillomaviruses, bovine papillomavirus, cancer, molecular epidemiology ptaquiloside, bladder
Citation: Medeiros-Fonseca B, Abreu-Silva AL, Medeiros R, Oliveira PA and Gil da Costa RM (2022) Corrigendum: Pteridium spp. and Bovine Papillomavirus: Partners in Cancer. Front. Vet. Sci. 9:860838. doi: 10.3389/fvets.2022.860838
Received: 23 January 2022; Accepted: 24 January 2022;
Published: 16 February 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Medeiros-Fonseca, Abreu-Silva, Medeiros, Oliveira and Gil da Costa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Rui M. Gil da Costa, rmcosta@fe.up.pt